One case of spontaneous hemorrhage of iliopsoas and gluteal muscles induced by drugss

doi:10.19803/j.1672-8629.20220460

Abstract

Abstract: Objective To review the process of treating one case of the iliopsoas and gluteal muscle hemorrhage caused by nadroparin,aspirin, efoperazone sodium and sulbactam sodium for injection so as to provide reference for clinical treatment. Methods The diagnosis and treatment of a patient with spontaneous iliopsoas and gluteal muscle hemorrhage and treated with the combination of nadroparin, aspirin, cefoperazone sodium and sulbactam sodium for injection was retrospectively analyzed. Results After conventional treatment, the hemorrhage of the iliopsoas and gluteal muscle improved, but hematoma was formed in psoas muscles. Conclusion Treatment with nadroparin, aspirin, cefoperazone sodium and sulbactam sodium for injection can possibly induce a rare deep muscle hemorrhage, which deserves attention clinically.

Key words: nadroparin, cefoperazone/sulbactam, aspirin, iliopsoas muscle hemorrhage, adverse drug reaction, drug interaction

CLC Number:

R972
R994.11

XIE Jing, GUAN Fei. One case of spontaneous hemorrhage of iliopsoas and gluteal muscles induced by drugss[J]. Chinese Journal of Pharmacovigilance, 2023, 20(11): 1299-1302.

References

[1] XU L, ZHANG WX, XU BM, et al.Opinions of pharmaceutical experts on clinical application of nadroparin[J]. Shanghai Medical & Pharmaceutical Journal(上海医药), 2022, 43(21): 6.
[2] Dingxiangyuan. Nodroparin: Drug monograph(Topic1006 Version220.0) [EB/OL]. [2023-02-06]. https://www.uptodate.com/contents/zh-Hans/94072?kp_tab=drug_dxy&display_rank=1&search=nodroparin selected Title=1~25&source=panel_search_result.
[3] AGNELLI G, DEL FAVERO A, PARISE P, et al.Cephalosporin-induced hypoprothrombin- -emia: Is the N-methylthiotetrazole side chain the culprit?[J]. Antimicrob Agents Chemother, 1986, 29(6): 1108-1109.
[4] SCHENTAG JJ, WELAGE LS, WILLIAMS JS, et al.Kinetics and action of N-methylthiotetr-azole in volunteers and patients. Population-based clinical comparisons of antibiotics with and without this moiety[J]. Am J Surg, 1988, 155(5A): 40-44.
[5] LIANG H, MENG GY, ZHONG LQ, et al.Research progress of coagulation dysfunction induced by cefoperazone sodium and sulbactam sodium[J]. China Pharmaceuticals(中国药业), 2020, 29(1): 3.
[6] ZHU YC,LIANG L,SHEN J,et al.Clinical features and risk factors of coagulation disorders caused by cefoperazone sodium and sulbactam sodium[J]. Chinese Pharmaceutical Journal(中国药学杂志), 2022, 57(9): 57.
[7] KIM JH, YOO SD, KIM DH, et al.Iliopsoas hematoma presenting with sudden knee extensor weakness: a case report[J]. Medicine (Baltimore), 2020, 99(50): e23497.
[8] UNDAS A, BRUMMEL K, MUSIAL J, et al.Blood coagulation at the site of microvascular injury: effects of low-dose aspirin[J]. Blood, 2001, 98(8): 2423-2431.
[9] WANG YY, ZHAI L.A case report of iliac muscle hematoma caused by low molecular weight heparin[J]. World Latest Medicine Information, 2021, 21(84): 288-290,293.
[10] MANSOR MFH, JUSOH AC, MOHD SM.Spontaneous iliopsoas hematoma in severe COVID-19 infection: a rising catastrophic complication[J]. Vis J Emerg Med, 2022, 27: 101308.
[11] VERGORI A, PIANURA E, LORENZINI P, et al.Spontaneous iliopsoas haematomas (IPHs): a warning for COVID-19 inpatients[J]. Ann Med, 2021, 53(1): 295-301.
[12] LI L,LI YF,WANG LP.Adverse event signal mining of low molecular weight heparin based on FAERS database[J]. Clinical Medication Journal(临床药物治疗学杂志), 2022(5): 43-49.
[13] BOUGET J, BALUSSON F, KERBRAT S, et al.Clinical use of low-dose parenteral anticoagulation, incidence of major bleeding and mortality: a multi-centre cohort study using the French national health data system[J]. Eur J Clin Pharmacol, 2022, 78(7): 1137-1144.
[14] FERNANDES C, PEREIRA P, RODRIGUES M. Spontaneous iliopsoas muscle haematoma as a complication of anticoagulation in acute cerebral venous thrombosis: to stop or not to stop (the anticoagulation)[J]. BMJ Case Rep, 2015, 6: bcr 2014206410.
[15] ARTZNER T, CLERE R, SCHENCK M, et al.Spontaneous iliopsoas hematomas complicating intensive care unit hospitalizations[J]. PLoS One, 2019, 14(2): e0211680.